Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0002962 (angina)
21,142 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

We report a case of sudden onset of angina 11 years after implantation of a No. 8 Model 2300 Starr-Edwards cloth-covered aortic valve prosthesis for aortic stenosis and insufficiency. At operation the cloth covering one strut of the metal cage was tenuously attached to the ring of the prosthesis, with its free end completely occluding the right coronary artery ostium. The valve was replaced and the obstructing foreign body removed, re-establishing the patency of the right coronary artery.
...
PMID:Right coronary artery occlusion by cloth from a Starr-Edwards aortic valve prosthesis. 608 35

Although permanent stents have been successfully used as bail-out devices in the treatment of abrupt occlusion, the risk of stent thrombosis and of bleeding complications, as well as the cost of a prolonged hospitalization, have been deterrents to their universal acceptance. Temporary stents were conceived to provide internal scaffolding of the coronary arteries, which could stabilize occlusive dissections, yet still allow the stent to be removed before the time of peak incidence of subacute thrombosis. The ACS RX flow support catheter is a prototype temporary stent which has been recently evaluated in phase I and II clinical trials. The device is effective in improving angina score, coronary flow, and decreasing residual stenosis when used in cases of suboptimal percutaneous interventional results. However, the incidence of major complications and the need for adjunctive percutaneous interventions remain significant. Further studies are needed to define the optimal time of cage expansion as well as the clinical, anatomical, and procedural factors that predict efficacy and safety of this new device.
...
PMID:Temporary stents: the ACS RX flow support catheter. 1015 Oct 63

Cardiac computed tomographic angiography (CTA) allows for simultaneous evaluation of the lung fields and associated structures. There is a debate as to the benefit of or need for routine overread of the lung fields for incidental findings. The possible improvement in cancer diagnosis with routine overreads is balanced against the major limitations of CT lung screening. Current limitations include (a) a high rate of nodule detection given that >50% of participants may have at least one noncalcified nodule; (b) the increased costs and radiation exposure associated with the resulting follow-up CT scans; (c) the cost and the morbidity of follow-up, including further testing, as well as biopsy or resection of benign noncalcified nodule (at least 25% of such procedures in several trials); (d) a small but difficult to quantify potential risk of cancer associated with multiple follow-up CT scans; and (e) a potential for increased anxiety of both the patient and the physician about nonsignificant pathology. All of these limitations are balanced against a possibility that this could lead to an earlier detection of lung cancer with the consequent improvement in the chances of the patients' survival. Extensive studies of screening CT in older smokers have revealed the prevalence of cancer to be between 0.3 and 1%. However, when applied to an ambulatory population of patients presenting for an evaluation of angina, the prevalence of lung cancer or significant non-cardiac findings may be significantly lower. We have reviewed all the relevant literature and sought to determine the potential benefits and harms of specifically overreading CTA for non-cardiac pathology. The weight of the evidence suggests that it is most prudent to not specifically reconstruct and re-read CTA scans for lung nodules. If a non-cardiac abnormality is visualized by the primary interpreter of the cardiac CT, appropriate referral or follow-up is prudent.
...
PMID:Incidental findings with cardiac CT evaluation: should we read beyond the heart? 1763 Jun 79